The FDA has approved the first vaccine to protect infants against RSV, a respiratory virus that can be deadly.

The new shot, from Pfizer, will be given to pregnant mothers.

In clinical trials, it reduced the risk of severe RSV by 82% for newborns.

But before the shot is ready for the public, the Centers for Disease Control and Prevention need to also give it the green light.